comparemela.com

Latest Breaking News On - கரோலினா சிறுநீரக ஆராய்ச்சி மையம் - Page 2 : comparemela.com

Sesen Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Significant Regulatory and Commercial Readiness Progress for the Company s Lead Product Candidate Vicineum™

Published: Mar 15, 2021 March 15, 2021 11:00 UTC Sesen Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Significant Regulatory and Commercial Readiness Progress for the Company’s Lead Product Candidate Vicineum™ Strengthened balance sheet: $98 million in cash and cash equivalents as of February 28, 2021 1 Marketing Authorization Application submitted in Europe with potential approval in early 2022     Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported operating results for the fourth quarter and full-year ended December 31, 2020. The Company’s lead program, Vicineum, also known as VB4-845, is currently in the follow-up stage of a Phase 3 registration trial for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). In February 2021, the Food and Drug Administration (FDA) accepted for filing the Company s Biologi

Prostate Cancer Screenings on the Decline with Concerns Surrounding COVID-19: What Men Should Know

Posted Monday, February 22, 2021 10:01 am (BPT) - In the early part of the COVID-19 pandemic, many areas of the country banned nonessential medical procedures in an effort to slow the spread of the disease. As a result, many physicians saw fewer patients for routine medical care, such as physical exams and screenings. A recent survey by The Physicians Foundation polled 3,513 physicians and found 41% saw volume decreases of 26% or more in their practices. The impact on cancer screenings was even more profound. For example, screenings for prostate cancer one of the most commonly diagnosed cancers in men in the United States dropped by 56% by the peak of the pandemic in April according to a recent study published in

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.